225 related articles for article (PubMed ID: 24533232)
21. Contraceptive use following gestational trophoblastic disease: A systematic review.
Hagey JM; Drury KE; Kaplan S; Davidson BA; Morse JE
Contraception; 2024 May; ():110488. PubMed ID: 38763274
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
23. Low-risk gestational trophoblastic neoplasia - 20 years experience of a state registry.
McInerney C; McNally O; Cade TJ; Jones A; Neesham D; Naaman Y
Aust N Z J Obstet Gynaecol; 2023 Nov; ():. PubMed ID: 37964485
[TBL] [Abstract][Full Text] [Related]
24. Update on the diagnosis and management of gestational trophoblastic disease.
Ngan HYS; Seckl MJ; Berkowitz RS; Xiang Y; Golfier F; Sekharan PK; Lurain JR; Massuger L
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():79-85. PubMed ID: 30306586
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report.
Okada Y; Miyamoto S; Mimura T; Ishikawa T; Sekizawa A; Matsumoto K
BMC Womens Health; 2019 Jul; 19(1):101. PubMed ID: 31337386
[TBL] [Abstract][Full Text] [Related]
27. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
28. Cervical gestational trophoblastic neoplasia: A rare form of gestational trophoblastic disease.
Jaiswar SP; Agrawal M; Deo S; Saad S
J Cancer Res Ther; 2022; 18(3):827-830. PubMed ID: 35900567
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients.
Hidayat YM; Darmadi A E; Rachmayati S; Kusumah WP; Djuwantono T; Pramatirta AY; Suardi D
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3325-3329. PubMed ID: 33247691
[TBL] [Abstract][Full Text] [Related]
30. High HIV prevalence in gestational trophoblastic neoplasia patients.
Parker VL; Baker ZLI; Stone BJ; Singh K; Winter MC; Palmer JE
AIDS; 2024 Jan; 38(1):69-73. PubMed ID: 37816174
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature.
Kong Y; Tao G; Zong L; Yang J; Wan X; Wang W; Xiang Y
Front Oncol; 2019; 9():1262. PubMed ID: 31803628
[No Abstract] [Full Text] [Related]
32. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease.
Lok C; van Trommel N; Massuger L; Golfier F; Seckl M;
Eur J Cancer; 2020 May; 130():228-240. PubMed ID: 32247260
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
34. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
35. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
36. Choriocarcinoma and gestational trophoblastic disease.
Smith HO; Kohorn E; Cole LA
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):661-84. PubMed ID: 16310678
[TBL] [Abstract][Full Text] [Related]
37. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
Faranesh R; Ben-David Y
Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
[TBL] [Abstract][Full Text] [Related]
38. Gestational Trophoblastic Disorders: An Update in 2015.
Stevens FT; Katzorke N; Tempfer C; Kreimer U; Bizjak GI; Fleisch MC; Fehm TN
Geburtshilfe Frauenheilkd; 2015 Oct; 75(10):1043-1050. PubMed ID: 26556906
[TBL] [Abstract][Full Text] [Related]
39. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN).
Shahbazian N; Razi T; Razi S; Yazdanpanah L
Med J Islam Repub Iran; 2014; 28():78. PubMed ID: 25405143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
